Dr. Szymon Hryhorowicz joined the Department of Nucleic Acid Functions in 2014. He is a graduate of the interdisciplinary PhD program at the NanoBioMedical Center, Adam Mickiewicz University in Poznan, Poland.
He specializes in mutation studies, SNPs, gene expression and sequencing research.
Dr. Hryhorowicz’s research interests focus on the role of the endocannabinoid system in inflammatory bowel disease. In particular, on the molecular mechanisms controlling the activation of CB1 and CB2 cannabinoid receptors in mucosal inflammation and the expression profile of genes involved in cannabinoid metabolism.
He has held foreign internships at Max Delbrück Center for Molecular Medicine in Berlin and China National Research Institute of Food and Fermentation Industries in Beijing.